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Summary
Cytokinesis is the final step of cell division and leads
to the physical separation of the daughter cells. After
the ingression of a cleavage membrane furrow that
pinches the mother cell, future daughter cells spend
much of the cytokinesis phase connected by an inter-
cellular bridge. Rab proteins aremajor regulators of in-
tracellular transport in eukaryotes [1], and here, we re-
port an essential role for human Rab35 in both the
stability of the bridge and its final abscission. We
find that Rab35, whose function in membrane traffic
was unknown, is localized to the plasma membrane
and endocytic compartments and controls a fast en-
docytic recycling pathway. Consistent with a key re-
quirement for Rab35-regulated recycling during cell
division, inhibition of Rab35 function leads to the ac-
cumulation of endocytic markers on numerous cyto-
plasmic vacuoles in cells that failed cytokinesis. More-
over, Rab35 is involved in the intercellular bridge
localization of twomolecules essential for the postfur-
rowing steps of cytokinesis: the phosphatidylinositol
4,5-bis phosphate (PIP2) lipid [2–4] and the septin
SEPT2 [5]. We propose that the Rab35-regulated path-
way plays an essential role during the terminal steps
of cytokinesis by controlling septin and PIP2 subcel-
lular distribution during cell division.
Results and Discussion
Recent genome-wide RNAi-based screens highlighted
the fact that intracellular transport is essential for animal
cytokinesis [6–8], with both the secretory and the endo-
cytic pathways being implicated in the late phases of cy-
tokinesis [9–17]. Among the key regulators of membrane
trafficking in eukaryotes, Rab GTPases represent a large
family of proteins that define particular routes within the
secretory and endocytic pathways by controlling sev-
eral transport steps such as vesicle formation, motility,
docking, and fusion [1]. In particular, Rab11 is required
for cytokinesis in a variety of systems [9, 18], and it
has been the only Rab implicated so far in this process
*Correspondence: arnaud.echard@curie.fr
2 Present address: Plate-forme de Microscopie Electronique, Institut
Pasteur, 28 rue du Dr Roux, 75724 Paris Cedex 15, France.in mammalian cells [12]. To determine whether other
Rabs are required for cytokinesis, we used RNA interfer-
ence (RNAi)-mediated gene inactivation to test which
ones are essential for this process. The Rab family in
mammals is large (>60 members), and the presence of
multiple isoforms that could be functionally redundant
complicates such an analysis [19]. Because many cyto-
kinesis genes are conserved among metazoans [17], we
decided to first identify which Rabs are essential for
cytokinesis in Drosophila, which encodes fewer Rab
proteins and in which RNAi is efficient. We thus system-
atically down-regulated each of the 29 Rab genes in
Drosophila S2-cultured cells and monitored the appear-
ance of binucleated cells as an indicator of cytokinesis
failure (Figure 1A). An increase in binucleated cells was
observed after Rab5 and Rab11 depletion. This finding
is consistent with previous work showing that Rab5
and Rab11 proteins are implicated in Drosophila cellula-
rization, an event that is related to cytokinesis [18]. How-
ever, inactivation of Drosophila Rab35 led to the stron-
gest increase in binucleated cells, with 20% cells after
a 6 day RNAi treatment (Figure 1A); this result indicates
that this Rab is essential for cytokinesis.
Rab35 is phylogenetically conserved in metazoans,
with a single orthologous gene being expressed in hu-
mans [19]. To investigate whether human Rab35 is in-
volved in cytokinesis, we monitored division in HeLa
cells after the inhibition of Rab35 function either by over-
expression of a dominant-negative mutant (Rab35
S22N) or after RNAi-mediated depletion. We first ana-
lyzed the accumulation of multinucleated cells on fixed
samples after transfection of the Rab35 S22N mutant
for 3 days and observed a 13.5-fold increase of binucle-
ated cells above background levels (21.9% 6 1.2% ver-
sus 1.6%6 0.2% in controls, n = 3, >500 cells per exper-
iment, t test p < 0.001). This phenotype was consistent
with a specific inhibition of Rab35 function because
the number of binucleated cells also increased by
3.5-fold (4.1% 6 0.4% versus 1.1% 6 0.2% in controls,
n = 3, >500 cells per experiment, t test p = 0.004) after re-
duction of Rab35 protein levels by a 5 day RNAi treat-
ment. Importantly, inhibition of Rab35 function by either
RNAi or Rab35 S22N overexpression did not affect the
levels of endogenous Rab5 and Rab11, suggesting
that impairing Rab35 function has a direct effect on cy-
tokinesis (see Figure S1 in the Supplemental Data avail-
able with this article online). We conclude from these ob-
servations that Rab35, as inDrosophila cells, is essential
for cytokinesis in human cells.
To determine at which stage of cytokinesis Rab35 is
required, we analyzed by time-lapse microscopy the
progression through mitosis after inhibition of Rab35
function. Videomicroscopy analysis revealed that mi-
totic cell rounding, anaphase progression, cell elonga-
tion, and furrow ingression appeared normal after
Rab35 S22N overexpression (Figure S2) or reduction of
Rab35 levels by RNAi (Figures 1B and 1C). In both cases,
binucleated cells arose from a destabilization of the
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1720Figure 1. Rab35 Is Required for Postfurrowing Steps of Cytokinesis
(A)Drosophila S2 cells were treated for 3 days or 6 days with dsRNA that interfered with each Rab gene encoded by the Drosophila genome. The
number of multinucleated cells in each condition was counted (mean 6 SEM, n = 3, >500 cells per condition) and representedw1% to 2% in
control experiments. For comparison, inactivation of the cytokinesis genes pebble and diaphanous led to 37% and 4% binucleated cells at
day 3 and 63% and 23% at day 6, respectively.
(B) After control or Rab35 RNAi, extracts from HeLa cells were analyzed by Western blot with Rab35 antibodies to monitor protein knockdown
efficiency after a 5-day treatment. b-tubulin levels were used as a loading control.
(C) Selected phase contrast time-lapse videomicroscopy frames from HeLa cells after Rab35 RNAi. This cell entered mitosis 100 hr posttrans-
fection, progressed normally through mitosis, and formed an intercellular bridge (marked by white arrowheads) that destabilized (marked by
black arrowheads), giving rise to a binucleated cell (marked by black arrows). Cytokinesis failed in 27/911 (3%) dividing cells after Rab35 knock-
down. In comparison, it failed in 6/663 (0.9%) control cells. These results are in agreement with fixed cell analysis (see text). The scale bar
represents 10 mm.intercellular bridge (Figures S2 and 1C), indicating that
Rab35 is required for stabilizing the cytokinesis bridge
connecting daughter cells after furrow ingression. In ad-
dition, the time required for abscission was strongly
increased in the cells that did not become binucleated
after Rab35 S22N overexpression or after Rab35 knock-
down by RNAi (Figure S3). We conclude that both
dominant-negative and RNAi-mediated depletion ap-
proaches demonstrate that Rab35 is required in human
cells for the postfurrowing terminal steps of cytokinesis,
namely for bridge stability and abscission. Because
RNAi-mediated Rab35 depletion was not complete
even after prolonged treatment (Figure 1B) and led to
a similar but less penetrant cytokinesis phenotype, we
used the dominant-negative approach as a tool to po-
tently inhibit Rab35 function in the experiments de-
scribed hereafter in this work.
To get insight into Rab35 function during the postfur-
rowing steps of cytokinesis, we next investigated its
localization and its role in membrane trafficking. Two
rabbit antisera were raised against recombinant hu-
man Rab35. They specifically recognized endogenous
Rab35 protein in HeLa cell extracts, as demonstrated
by the reduction of the signal after RNAi (Figure 1Band data not shown). After fractionation of postnuclear
supernatant, endogenous Rab35 was found to be pre-
dominantly (w70%) associated with cell membranes
(data not shown). Immunofluorescence and immuno-
electron microscopy (EM) experiments revealed that
endogenous Rab35 was associated with the plasma
membrane and internal structures (Figures 2A and 2B).
To further investigate Rab35 localization to the plasma
membrane, we transfected cells with PLC-d-PH-GFP,
a probe for the phosphatidylinositol 4,5-bis phosphate
(PIP2) [20]. Most Rab35 was detected in PIP2-positive
domains (Figure 2A, arrowheads), although it could
also be found in areas devoid of PIP2 (Figure 2A, ar-
rows). Quantification of EM sections indicated that
about 30% of the endogenous Rab35 was associated
with the plasma membrane, where it concentrated at
membrane extensions and on clathrin-coated pits
(Figure 2Bi; see also Figure S4). Double-labeling experi-
ments with internalized transferrin revealed that Rab35
localized to endocytic clathrin-coated vesicles (Figures
2Bi–2Bii) and that w10% of endogenous Rab35 was
present on sorting endosomes and endosomal tubules
(Figure 2Biv; see also Figure S4). A small pool of endog-
enous Rab35 was also found on vesicles that were
An Essential Role for Rab35 in Cytokinesis
1721Figure 2. Rab35 Is Localized to the Plasma Membrane and to Endocytic Compartments and Colocalizes with PIP2 to the Intercellular Bridge
during Cytokinesis
(A) HeLa cells were transfected with a PLC-d-PH-GFP (a PIP2 probe)-encoding plasmid for 24 hr and processed for immunofluorescence (GFP is
in green, endogenous Rab35 is in red, and DAPI is in blue). The left panel displays overlay channels of an entire cell and a zoom region of the
plasma membrane. Middle and right panels correspond to single staining in gray levels as indicated. Rab35 largely colocalized with PIP2 at
the plasma membrane (arrowheads) but was also found in structures lacking PIP2 (arrows). Scale bars represent 10 mm.
(B) Immuno-EM localization of endogenous Rab35 (10 nm gold particles) (i) or Rab35 (10 nm) and biotin (15 nm) (ii–iv) after a 30 min uptake of
biotinylated transferrin (Tf). In (i), P indicates plasma membrane, arrowheads mark membrane protrusions, and the arrow marks a clathrin-coated
vesicle. In (ii), the arrow marks a clathrin-coated vesicle. In (iii), the arrows mark the peri Golgi (G) area. (iv) shows endocytic recycling transport
intermediates. Scale bars represent 200 nm. See Figure S4 for quantification.
(C) PLC-d-PH-GFP (green) and Rab35 (red) localizations in mitotic HeLa cells processed as described in (A). Overlay stainings of successive
stages of mitosis (metaphase, anaphase, and telophase) are displayed in the upper panels, and single stainings are displayed in gray levels.
Rab35 and PIP2 largely colocalize at the ingressing furrow and at the midbody region during late cytokinesis (arrowheads). Scale bars represent
10 mm. In (A) and (C), each image corresponds to a single plane.transferrin-negative and located in close vicinity to
the Golgi apparatus, but not within the Golgi stacks
(Figure 2Biii; see also Figure S4). A Myc-tagged version
of Rab35 was found at the same locations as endoge-
nous Rab35 at the immunofluorescence and EM resolu-
tions (Figure S5). As in interphase cells, endogenous
Rab35 (Figure 2C) or Myc-tagged Rab35 (Figure S5)
was associated with the plasma membrane during mito-
sis and was present at the ingressing furrow during early
cytokinesis phases as well as at the intercellular bridge
later during cytokinesis. Interestingly, Rab35 colocal-
ized in these structures with PIP2, which was recently
shown to be enriched at the intercellular bridge during
cytokinesis [2, 4] (Figure 2C, arrowheads).
The localization of Rab35 prompted us to test whether
it controls trafficking between the plasma membrane
and endocytic compartments. We first investigated thepossible role of Rab35 during initial steps of endocytosis
and found that cells expressing Rab35 S22N internalized
surface-bound transferrin with identical initial rates as
those of control cells (Figure 3A, time points <10 min).
However, internalized transferrin recycled back to the
extracellular medium with slower kinetics in cells ex-
pressing Rab35 S22N (Figure 3A, time points >15 min),
suggesting that Rab35 regulates a recycling step. To di-
rectly demonstrate that Rab35 was involved in a recy-
cling pathway, we loaded cells with fluorescently la-
beled transferrin for 30 min and measured the kinetics
of chase after transfer into a medium containing unla-
beled transferrin. Half of the internalized transferrin re-
cycled back to the plasma membrane within 26 min 6
2 min in cells expressing the Rab35 S22N mutant, as
compared to 16 min 6 2 min in control cells (Figure 3B),
indicating that recycling was perturbed. At least two
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1722Figure 3. Rab35 Controls a Fast Recycling Transport Step from Endosomal Compartments to the Plasma Membrane
HeLa cells were transfected with either control (blue curve) or dominant-negative Rab35 S22N (red curve)-expressing plasmids for 72 hr.
(A) Internalization and recycling of surface bound transferrin; fluorescently labeled transferrin was bound to the cell surface for 45 min at 4C.
Nonspecific binding was washed out, and cells were allowed to internalize and recycle transferrin for different times (x axis) at 37C. The intra-
cellular, labeled transferrin was quantified, and results were expressed as the fraction of initial surface bound transferrin (y axis) (mean 6 SEM,
n = 3, >2000 cells were analyzed by cytometry for each time point). Note that the number of TfR at the surface was reduced in Rab35 S22N-
expressing cells compared to control cells but that initial rates of internalization were identical (see text).
(B) Transfected cells were loaded with fluorescently labeled transferrin by continuous uptake at 37C for 30 min. TfR recycling to the cell surface
was measured by quantification of intracellular, labeled transferrin (y-axis) that remained after different chase times at 37C (x-axis) into a me-
dium containing unlabeled transferrin. The results are expressed as the intracellular fraction of the loaded transferrin (mean6 SEM, n = 3, 2000–
9000 cells were analyzed by cytometry for each time point). (B inset) Fast recycling after a 5 min chase was measured as described above in HeLa
cells transfected with control, Rab35 S22N-, Rab35 wild-type-, or Rab35 Q67L-encoding plasmids 72 hr posttransfection. The results are ex-
pressed as the fraction of loaded transferrin that was released from cells for each condition (mean6 SEM, n = 4, 2000–9000 cells were analyzed
per experiment). Fast recycling is strongly inhibited by the Rab35 S22N mutant, whereas overexpression of wild-type or GTP-locked Rab35 Q67L
mutant significantly increases fast recycling; paired t test values were p = 0.02 and p = 0.001 for * and ** comparisons with control, respectively.recycling pathways have been described in mammalian
cells: a direct or fast recycling pathway that operates
from peripheral endocytic compartments and a slow
recycling pathway that recycles molecules back to the
plasma membrane from deeper compartments with
slower kinetics. Recycling rates for chase times of
more than 15 min did not appear to be significantly af-
fected in cells overexpressing Rab35 S22N, suggesting
that slow recycling was not perturbed (Figure 3B). Strik-
ingly, the fast recycling, as measured after a 5 min
chase, appeared strongly reduced in cells expressing
Rab35 S22N (Figure 3B, inset). Conversely, overexpres-
sion of wild-type or GTPase-deficient (GTP-locked)
Rab35 Q67L mutant significantly increased fast recy-
cling (paired t test with p = 0.02 and p = 0.001, respec-
tively, n = 4, >2000 cells per experiment) (Figure 3B, in-
set), suggesting that Rab35 is an essential rate-limiting
regulator of fast recycling. The involvement of Rab35
in a recycling transport step to the plasma membrane
was further confirmed by the observation that the
amount of transferrin receptor (TfR) at the cell surface
was reduced in cells overexpressing Rab35 S22N (Fig-
ure S6). Quantification by FACS cytometry indeed
revealed a 2-fold reduction in the number of surface
binding sites for transferrin (52% 6 3% of control,
mean 6 SEM, n = 6, >2000 cells analyzed per experi-
ment), which is consistent with a defective recycling of
receptors back to the PM in Rab35 S22N-expressingcells. We conclude from the above experiments that
Rab35 is not involved in an internalization transport
step butcontrols a fast recycling pathwaybackto the PM.
To investigate whether defective recycling could be
the cause of the cytokinesis defects in Rab35 S22N-
expressing cells, we analyzed TfR recycling during early
and late phases of cytokinesis. Given the brief time
frame of furrow ingression in anaphase and bridge for-
mation in telophase, it was technically not feasible to
directly measure transferrin recycling during these par-
ticular phases of the cell cycle by cytometry, as we
did in interphase cells. However, amounts of plasma-
membrane-associated TfR were reduced during furrow
ingression (Figures 4A and 4B) and when intercellular
bridges still connected daughter cells (Figures 4C and
4D) after Rab35 S22N expression. Semi-quantitative
analysis of immunofluorescence images revealed
a mean 2-fold reduction of surface TfR levels during cy-
tokinesis in Rab35 S22N-expressing cells; this reduction
is in good agreement with values obtained in interphase
cells. This result indicates that, as in interphase cells, re-
cycling to the cell surface is also impaired during cytoki-
nesis upon Rab35 inhibition. Consistent with a defective
recycling, the TfR accumulated in numerous intracellular
vacuoles that formed in approximately 30% of posttelo-
phase cells that failed cytokinesis after Rab35 S22N
overexpression (Figure 4G); such localization was never
seen in control cells (Figure 4E). This abnormal
An Essential Role for Rab35 in Cytokinesis
1723Figure 4. Rab35 Functions in a Recycling Step during Cytokinesis That Controls PIP2 and SEPT2 Localization to the Intercellular Bridge
(A–D) HeLa cells were transfected with control (A and C) or Rab35 S22N (B and D)-encoding plasmids for 72 hr and processed for immunoflu-
orescence. Cells during cytokinesis furrow ingression (early cytokinesis shown in [A] and [B]) or connected by an intercellular bridge (late cyto-
kinesis shown in [C] and [D]) were stained in green for TfR without permeabilization (surface TfR labeling). TfR recycling to the plasma membrane
during all phases of cytokinesis was reduced in mutant cells compared to controls.
(E–P) HeLa cells were transfected with control (E, H, K, and N) or Rab35 S22N mutant-encoding plasmids (F–G, I–J, L–M, and O–P) for 72 hr and
processed for immunofluorescence. Transfected cells were outlined in white where it was necessary. In (H)–(J), the PLC-d-PH-GFP-encoding
plasmid was cotransfected. Cells were stained for TfR (total TfR staining after permeabilization) in (E)–(G), for GFP in (H)–(J), for SEPT2 in (K)–
(M), and for F-actin (phalloidin) in (N)–(P). Corresponding stainings are displayed in gray levels and have been overlaid with DAPI in blue. Cells
in the first two rows are in cytokinesis and are still connected by an intercellular bridge, as shown in upper-left insets (Rabkinesin-6 stainings in
[E]–[F] and [H]–[I] or tubulin stainings in [K]–[L], and [N]–[O] in red). Cells in (G), (J), (M), and (P) were fixed after cytokinesis failed and contained
two nuclei. In contrast to punctuated structures observed in control cells (E), the TfR accumulates on numerous intracellular vacuoles in the
Rab35 S22N-expressing cells (F–G). PIP2 and the septin SEPT2 are restricted to the plasma membrane and are enriched at the intercellular
bridge during cytokinesis in control cells (H and K) but not in Rab35 S22N-expressing cells (I and L). PIP2 and SEPT2 instead accumulated
on intracellular vacuoles (I–J and L–M). Mislocalization of TfR, PIP2, and SEPT2 markers on intracellular vacuoles is displayed at a higher
magnification in bottom-left zoom regions. In contrast to PIP2 and SEPT2, F-actin was normally enriched at the intercellular bridge in Rab35
S22N-expressing cells (O), as observed in controls (N). In addition, F-actin was enriched on large intracellular vacuoles after cytokinesis failed
(P; see text). Each image corresponds to a single confocal plane. Scale bars represent 20 mm.localization was observed not only after cytokinesis
failed (Figure 4G) but also when the daughter cells
were still connected before the bridge destabilized
(Figure 4F). The reduction of endogenous Rab35 by
RNAi was not complete (Figure 1B), which likely explains
why no intracellular vacuoles were observed in Rab35-
depleted cells. However, the number of Rab35 S22N-
overexpressing cells that formed vacuoles increased
by 58% 6 5% after endogenous Rab35 knockdown
(>300 cells per experiment, n = 5, t test p = 0.005, see
the Supplemental Experimental Procedures for details).
In addition, we never observed the formation of vacu-
oles in cells that overexpressed dominant-negative mu-
tants of two Rab proteins involved in endocytic recycling
(Rab4 and Rab11) and cytokinesis (Rab11). These re-
sults are consistent with a specific inhibition of Rab35
recycling function by Rab35 S22N.
The stability of the intercellular bridge and the abscis-
sion step of cytokinesis involve targeted membrane
addition close to the midbody region and theestablishment of particular protein and lipid domains
within the bridge [15, 16]. In particular, it has been shown
that production and turnover of PIP2 are required for cy-
tokinesis in different organisms [2–4, 21–23] and that
PIP2 localization at the bridge is essential for bridge sta-
bility and cytokinesis completion in mammalian cells [2].
As recently reported [2, 4], we found that PIP2 is associ-
ated to the plasma membrane and greatly enriched at
the intercellular bridge during late stages of cytokinesis
in control cells (Figure 4H). Interestingly, quantifications
on fixed samples revealed that 55% of the intercellular
bridges connecting daughter cells expressing Rab35
S22N (n = 75) lacked any PIP2 enrichment (Figure 4I);
in comparison, 24% of control bridges (n = 75) lacked
PIP2 enrichment at the same stage of cytokinesis
(Figure 4H). In addition, PIP2 was found to mislocalize
into the intracellular vacuoles positive for TfR in Rab35
S22N-overexpressing cells when they were still con-
nected by an intercellular bridge (Figure 4I) or when
cytokinesis already failed (Figure 4J). Moreover, the
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intercellular bridge after Rab35 S22N overexpression
was increased by 27% after endogenous Rab35 knock-
down by RNAi (n = 55). We thus conclude that Rab35
contributes to the proper localization and maintenance
of PIP2 at the intercellular bridge during cytokinesis.
How exactly PIP2 contributes to cytokinesis is cur-
rently unknown, but it could recruit cytoskeletal pro-
teins, such as septins, that are essential for this process.
The septin SEPT2 is enriched at the furrow and at the in-
tercellular bridge during cytokinesis [5] and is likely to
bind to PIP2 via a conserved basic domain, as already
shown for SEPT4/Septin H5 [24]. Because functional in-
activation of SEPT2 in mammalian cells leads to cytoki-
nesis defects similar to those observed after Rab35 inhi-
bition (binucleated cells and abnormal abscission) [5],
we thus analyzed the localization of this septin in
Rab35 S22N-expressing cells. We found that, as shown
for PIP2, 52% of the intercellular bridges connecting
daughter cells expressing Rab35 S22N (n = 33) dis-
played no SEPT2 enrichment (Figure 4L); in comparison,
only 15% of control bridges (n = 33) displayed no SEPT2
enrichment at the same stage of cytokinesis (Figure 4K).
Instead, SEPT2 was found on intracellular vacuoles
when cells were still connected (Figure 4L) or after cyto-
kinesis failed (Figure 4M). By contrast, anillin (data not
shown) and F-actin (Figures 4N–4O) were properly local-
ized at the ingressing furrow and at the intercellular
bridge after Rab35 S22N overexpression. We noticed
that F-actin often localized on the very large intracellular
vacuoles that grew after cytokinesis failed (Figure 4P). A
likely hypothesis is that PIP2 progressively induces actin
polymerization at the surface of these vacuoles. More-
over, anillin was exceptionally found on those very large
vacuoles (data not shown). Because SEPT2 and PIP2
localization at the bridge are required for its stability
and cytokinesis completion in mammalian cells [2, 5],
we propose that the Rab35-regulated pathway has an
essential role for cytokinesis in controlling PIP2 and
SEPT2 localization during the late stages of cytokinesis.
In conclusion, we report that Rab35 is a regulator of an
endocytic recycling pathway that is essential for bridge
stability and abscission. Such a requirement in cytokine-
sis is likely to be phylogenetically conserved in meta-
zoans because Rab35 is essential for this process in
both Drosophila and human cells. Rab11 is another
Rab essential for cytokinesis in mammals and is re-
quired after furrow ingression [12]. Interestingly, Rab11
and Rab35 are localized to different subcellular com-
partments and control distinct endocytic recycling
pathways ([1] and this study), suggesting that multiple
endocytic routes are individually essential for cytokine-
sis. Finally, our work reveals that the Rab35-regulated
pathway contributes to the SEPT2 and PIP2 lipid locali-
zation at the intercellular bridge during late cytokinesis
and helps us to understand how lipid domains that
are essential for the terminal steps of cytokinesis are
established.
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